Advisor Group Holdings, Inc. Xenetic Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.6 - $1.14 $360 - $683	-600 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.88 - $1.37 $528 - $822	600 New	600 $1,000
Q3 2021 Nov 05, 2021	SELL	$1.73 - $5.3 $8,650 - $26,500	-5,000 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$1.57 - $2.45 $7,850 - $12,250	5,000 New	5,000 $10,000
Q4 2020 Feb 10, 2021	SELL	$0.79 - $3.17 $2,370 - $9,510	-3,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$0.83 - $1.56 $2,490 - $4,680	3,000 New	3,000 $3,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.